Expression of VEGF isoforms and their receptors in uterine myomas

被引:3
作者
Plewka, Danuta [1 ]
Morek, Michal [2 ]
Bogunia, Edyta [2 ]
Waloszek, Jozef [2 ]
Plewka, Andrzej [2 ]
机构
[1] Med Univ Silesia, Chair Histol & Embryol, Dept Cytophysiol, SMK Katowice, PL-41200 Sosnowiec, Poland
[2] Med Univ Silesia, Dept Prote, SPLMS Sosnowiec, Jednosci Str 8, PL-41200 Sosnowiec, Poland
关键词
VEGF; myoma; uterus; woman; ENDOTHELIAL GROWTH-FACTOR; ANGIOGENIC FACTOR; BLOOD-VESSELS; LEIOMYOMATA; THERAPY; SURVIVAL; DENSITY; CANCER; WOMEN; AGE;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: The aim of the study was to determine the expression of VEGF (vascular endothelial growth factor) isoforms and their receptors in uterine myomas. Material and methods: The study included 40 women with myomas of reproductive age and 40 perimenopausal women (the study group). Myometrial samples (the control group) were taken from 10 women undergoing hysterectomy for ovarian tumors and 10 older women undergoing hysterectomy for uterine prolapse. Results: A significantly increased expression of VEGF-A has been found in myomas, both small and large, in the younger women, which may by a sign of increased angiogenesis and intensive tumor growth. In perimenopausal women, the increase of VEGF expression was observed only in the endothelium and vascular smooth muscle. Conclusion: An important conclusion of this study is that angiogenesis is independent of myoma size, which may suggest intensive tumor growth and the related increased angiogenesis. High expression of VEGF-A and VEGF-R1 receptors in large myomas can probably cause malignant transformation and more extensive growth, regardless of patient age.
引用
收藏
页码:166 / 177
页数:12
相关论文
共 30 条
[1]   Fibroids, infertility and pregnancy wastage [J].
Bajekal, N ;
Li, TC .
HUMAN REPRODUCTION UPDATE, 2000, 6 (06) :614-620
[2]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[3]  
Blake RE, 2007, J NATL MED ASSOC, V99, P1170
[4]   Uterine myoma: a condition amendable to medical therapy? [J].
Cheng, Ming-Huei ;
Wang, Peng-Hui .
EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) :119-133
[5]  
Dobrzycka B, 2010, GINEKOL POL, V81, P422
[6]   Vascular endothelial growth factor: Basic science and clinical progress [J].
Ferrara, N .
ENDOCRINE REVIEWS, 2004, 25 (04) :581-611
[7]   Role of vascular endothelial growth factor in the regulation of angiogenesis [J].
Ferrara, N .
KIDNEY INTERNATIONAL, 1999, 56 (03) :794-814
[8]   Regulation of Angiogenesis by Oxygen and Metabolism [J].
Fraisl, Peter ;
Mazzone, Massimiliano ;
Schmidt, Thomas ;
Carmeliet, Peter .
DEVELOPMENTAL CELL, 2009, 16 (02) :167-179
[9]   Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor [J].
Fraser, HM ;
Dickson, SE ;
Lunn, SF ;
Wulff, C ;
Morris, KD ;
Carroll, VA ;
Bicknell, R .
ENDOCRINOLOGY, 2000, 141 (03) :995-1000
[10]  
Hague S, 2000, CLIN CANCER RES, V6, P2808